51 related articles for article (PubMed ID: 38637730)
1. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia.
Dobish KK; Wittorf KJ; Swenson SA; Bean DC; Gavile CM; Woods NT; Ghosal G; Hyde RK; Buckley SM
Leukemia; 2023 Nov; 37(11):2197-2208. PubMed ID: 37689825
[TBL] [Abstract][Full Text] [Related]
2. Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.
Kelly LM; Rutter JC; Lin KH; Ling F; Duchmann M; Latour E; Arang N; Pasquer H; Ho Nhat D; Charles J; Killarney ST; Ang HX; Namor F; Culeux C; Lombard B; Loew D; Swaney DL; Krogan NJ; Brunel L; Carretero É; Verdié P; Amblard M; Fodil S; Huynh T; Sebert M; Adès L; Raffoux E; Fenouille N; Itzykson R; Lobry C; Benajiba L; Forget A; Martin AR; Wood KC; Puissant A
Nat Cancer; 2024 May; ():. PubMed ID: 38816660
[TBL] [Abstract][Full Text] [Related]
3. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation.
Wang L; Zhao S; Wang Y; Liu J; Wang X
BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
[TBL] [Abstract][Full Text] [Related]
5. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
Yu K; Wang J; Hou J; Zhang L; Liang H
Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.
Huang J; Xiao R; Wang X; Khadka B; Fang Z; Yu M; Zhang L; Wu J; Liu J
Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476495
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
[TBL] [Abstract][Full Text] [Related]
8. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
Sun X; Yang S; Song W
Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis in acute leukemia.
Lyu T; Li X; Song Y
Chin Med J (Engl); 2023 Apr; 136(8):886-898. PubMed ID: 37010259
[TBL] [Abstract][Full Text] [Related]
10. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.
Zhang S; You X; Zheng Y; Shen Y; Xiong X; Sun Y
J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548081
[TBL] [Abstract][Full Text] [Related]
11. Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer.
Meng Y; Sun H; Li Y; Zhao S; Su J; Zeng F; Deng G; Chen X
Int J Biol Sci; 2022; 18(14):5475-5488. PubMed ID: 36147464
[TBL] [Abstract][Full Text] [Related]
12. UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis.
Zhou Y; Zhang J; Gong J; Tang X; Zhang C
Aging (Albany NY); 2022 Sep; 14(17):7003-7013. PubMed ID: 36069832
[TBL] [Abstract][Full Text] [Related]
13. UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation.
Cao JZ; Nie G; Hu H; Zhang X; Ni CM; Huang ZP; Qiao GL; Ouyang L
J Gastrointest Oncol; 2022 Jun; 13(3):1444-1453. PubMed ID: 35837197
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
